SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-058433
Filing Date
2010-12-03
Accepted
2010-12-03 18:02:00
Documents
1
Period of Report
2010-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3922
  Complete submission text file 0001209191-10-058433.txt   5606
Mailing Address
Business Address
WIGGANS THOMAS G (Reporting) CIK: 0001208907 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51665 | Film No.: 101232619

Mailing Address 3570 CARMEL MOUNTAIN ROAD SUITE 100 SAN DIEGO CA 92130
Business Address 3570 CARMEL MOUNTAIN ROAD SUITE 100 SAN DIEGO CA 92130 (858) 876-6500
Somaxon Pharmaceuticals, Inc. (Issuer) CIK: 0001339455 (see all company filings)

IRS No.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations